A Randomized, Double-Blind, Placebo Controlled, Crossover Trial to Evaluate Safety and Efficacy of AGY in Celiac Disease

NCT03707730 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

161

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DIETARY_SUPPLEMENT: AGY
OTHER: placebo

Sponsor

Igy Inc.

Collaborators

[object Object]